Cellesce Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 18
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $8.07M
Latest Deal Amount
  • Investors
  • 5

Cellesce General Information

Description

Developer of novel bioprocessing technology committed to the growth and expansion of organoids. The company's bioprocessing technology, built on biochemical and bioprocess engineering expertise from the University of Bath and cell and organoid biology expertise from Cardiff University, thereby assisting client organizations in commercializing organoid models which are powerful new enabling technology in drug discovery and regenerative medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Cardiff Medicentre
  • Heath Park
  • Cardiff CF14 4UJ
  • Wales, United Kingdom
+44 01225 000000

Cellesce Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellesce Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2020 $8.07M 000 Completed Generating Revenue
2. Early Stage VC 23-Mar-2018 00000 00.000 00.000 Completed Generating Revenue
1. Seed Round 12-Nov-2015 $140K $140K 00000 Completed Startup
To view Cellesce’s complete valuation and funding history, request access »

Cellesce Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view Cellesce’s complete cap table history, request access »

Cellesce Executive Team (7)

Name Title Board Seat Contact Info
Paul Jenkins Ph.D Chief Executive Officer & Board Member
Victoria Durban Ph.D Chief Operating Officer & Board Member
Marianne Ellis Co-Founder & Chief Technology Officer
Robert Snedden Company Secretary & Board Member
Julian Chaudhuri Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Cellesce Board Members (9)

Name Representing Role Since
Christopher Thompson Self Board Member 000 0000
Francis Bealin-Kelly Self Board Member 000 0000
John Allbrook Self Chairman 000 0000
Julian Chaudhuri Cellesce Co-Founder & Board Member 000 0000
Kate Rowley Ph.D Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Cellesce Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellesce Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SETsquared Partnership Accelerator/Incubator Minority 000 0000 000000 0
Development Bank of Wales Venture Capital Minority 000 0000 000000 0
New Grounds Venture Capital Venture Capital Minority 000 0000 000000 0
Innovate UK Government Minority 000 0000 000000 0
NC3Rs Government Minority 000 0000 000000 0
To view Cellesce’s complete investors history, request access »